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Objectives: Electroconvulsive therapy (ECT) is the most effective treatment for severe or
treatment resistant depression; however, the lack of widely accepted methods for determining
when ECT is indicated may contribute to disparities and variation in use. We examined receipt
of ECT among depressed patients in the largest coordinated health system in the US, the
Veterans Health Administration.
Methods: Using administrative data, we conducted a multivariable logistic regression to
identify individual clinical and sociodemographic predictors of receiving ECT, including
variables of geographic accessibility to ECT, among patients diagnosed with major depressive
disorder between 1999 and 2004.
Results: 307 (0.16%) of 187,811 patients diagnosed with major depression received ECT during
the study period. Black patients were less likely to receive ECT than whites (odds ratio 0.33;
95% confidence interval: 0.20, 0.55), and patients living in the South (OR: 0.71; 95% CI: 0.53,
0.95) or West (OR: 0.59; 95% CI: 0.42, 0.82) were less likely to receive ECT than patients living
in the central US. Patients whose closest VA facility provided ECT had a higher likelihood of
receiving ECT (OR: 3.02; 95% CI: 2.22, 4.10). Depressed patients with no major medical
comorbidities were also more likely to receive ECT (OR: 2.42; 95% CI: 1.65, 3.55).
Limitations: Findings are not adjusted for depression severity.
Conclusions: ECT use for major depression was relatively uncommon. Race, US region,
geographic accessibility, and general medical health were all associated with whether or not
patients received ECT. Clinicians and health systems should work to provide equitable access
and more consistent use of this safe and effective treatment.









Electroconvulsive therapy (ECT) is the most effective treat-
mentoption for severedepression (Carneyet al., 2003). Response
rates with ECT are also 50–70% among patients who have not
responded toprior antidepressant treatment (Prudic et al., 1990).
There are few contraindications to ECT, and the mortality rate
fromtheprocedure is comparable to receivinggeneral anesthesia
alone (Lisanby, 2007; Roy and Overdyk, 1997; Sartorius and
Hewer, 2007).
Although the efficacy and safety of ECT have a well-
established evidence base, there has been substantial variation
in its availability and use. In theUS, themost recent nationwide
data regarding ECT use are from a 1988–1989 survey of
psychiatrists that estimated the rate of ECT use at 4.9 patients
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per 10,000 people (0.05%) with 36.3% of metropolitan areas
reporting no ECT use (Hermann et al., 1995). When areas that
provided ECTwere ranked by rate of ECT use, there was a four-
fold difference in the rates between the 25th and 75th
percentile areas, which is a greater variation than for most
other medical procedures. The variability in ECT use was not
explained by the prevalence of depression; rather, the number
of psychiatrists and primary care physicians and state regula-
tions were the strongest predictors of ECT use.
Reducing disparities in access to and quality of healthcare is
a stated goal of the US Department of Health and Human
Services (USDepartment of Health andHuman Services, 2001).
The VA health system, the largest national health system in the
US, prioritizes the use of evidence-based treatments and has
established a minimum degree of uniformity in services
provided across all of its medical centers (Kizer, 1996).
Examining the use of ECTwithin the VAhealth systemprovides
an opportunity to determine the degree to which disparities
exist within a large coordinated US health system and may
provide guidance in achieving more equitable and effective
treatment of depression, both within the VA and other health
systems. Using VA administrative and clinical data, we
determined the overall prevalence of ECTuse among depressed
veterans and the degree to which use varied by proximity to a
VA medical center that provided ECT, by demographic and
clinical factors, and by region within the US.
2. Methods
2.1. Study population
We used data on patient clinical and demographic
characteristics from the VA National Registry for Depression
(NARDEP), which was created and maintained by the VA's
Serious Mental Illness Treatment Resource and Evaluation
Center (SMITREC) in Ann Arbor, Michigan (Blow et al., 2003).
Patients were included if they were diagnosed with major
depressive disorder and had at least one other visit with any
depression diagnosis or were treated with an antidepressant
medication during the period between April 1, 1999 and
September 30, 2004. Major depression diagnoses were
identified using the International Classification of Diseases,
Ninth Revision (ICD-9) diagnostic codes 296.2x and 296.3x.
Patients with schizophrenia, schizoaffective disorder, and
bipolar I disorder were excluded from the study.
2.2. Study measures
Patient use of ECT treatment was determined from current
procedural terminology (CPT) codes in the outpatient records
(90870 and 90871) and ICD-9 codes from surgery and
procedure records (94.26 and 94.27). We validated this
measure against computer-assisted chart reviews of 400
depressed patients with a history of a two-week psychiatric
hospitalization at an ECT-providing facility and found that use
of administrative codes had a sensitivity of 0.96 (95%
confidence interval [CI]: 0.78–0.99) and specificity of 0.997
(95% CI: 0.985–0.999) for identifying VA ECT use within this
population. We also manually reviewed each instance where
only one ECT treatment was identified in the administrative
records, as ECT is usually provided over several treatments, and
excluded these instances if therewasno clinical documentation
of ECT, assuming that this meant that the ECT treatment had
been recorded in error. We also included instances of ECT
provided by non-VA facilities that were recorded in the Fee
Basis Medical and Pharmacy System.
We obtained data from theNARDEP on patient demographic
characteristics including age (18–40, 40–49, 50–64, and ≥65),
sex, Hispanic ethnicity, and race (white, African–American,
other, and unknown), with “other” race including patients of
Asian, Native Hawaiian, Pacific Islander, or Native American
race/ethnicity and patients who were multi-racial. Psychiatric
comorbidity was defined as patients receiving any of the
following clinical diagnoses in the twelve months prior to
cohort entry: post traumatic stress disorder (PTSD), any other
anxiety disorder (panic disorder with or without agoraphobia,
generalized anxiety disorder, anxiety disorder not otherwise
specified, and all phobias), bipolar II disorder, any substance use
disorder, and any personality disorder. General medical comor-
bidities in the year prior to cohort entry were characterized
using the Charlson Comorbidity Index (scored as 0, 1, and N1)
(Charlson et al., 1987).
We derived two variables related to geographic accessibility:
mean distance to a facility providing ECT treatment andwhether
the patient's closest VA facility performed ECT treatment.
Distance was calculated as a straight-line distance to the VA
facility from themost densely populated area of the patient's zip
code (i.e., population centroid), as done in previous studies
(Druss and Rosenheck, 1997; McCarthy et al., 2007; Piette and
Moos, 1996). We also determined whether patients had a
service-connected disability (indicating some VA-recognized
disability stemming from injuries or conditions that occurred or
were exacerbated during military service) that could potentially
facilitate access to VA services. To measure regional variation in
ECT use, we categorized patient treatment location into one of
four US regions (Northeast, Central, West, and South). We also
determined in which of the 21 VA-defined service regions
(Veterans Integrated Service Networks [VISNs]), the patient
received ECT. VISNs encompass geographically contiguous
regions (except those containing Hawaii, Alaska, and Puerto
Rico) but cross state lines. Each VISN has a mental health service
leader who is responsible for implementing VA policy regarding
ECT use in their network.
2.3. Statistical analysis
We conducted bivariate analyses using Wilcoxon and chi-
square tests for continuous and categorical variables, respec-
tively. We fit multivariable logistic regression models with
ECT use as the dependent variable and independent variables
included patient demographic and clinical characteristics, an
indicator for whether the patients' closest VA facility
provided ECT, and US region. Statistical significance level
was set at alpha=0.05 for all analyses. Statistical analyses
were conducted using SAS software version 9.2.
3. Results
3.1. Study population
187,811 VA patients with major depression were included
in the study, of which 90% were male, 72% white, 15% black,
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and 6% Hispanic, and the mean age was 54 years old. 307
(0.16%) of these patients received ECT during the 5 1/2 year
study period.
3.2. Availability and regional variation of ECT
Out of 128 VA Medical Centers, 60 (47%) performed ECT.
Depressed patients who received ECT were more likely to
have the procedure available at their nearest VA facility than
depressed patients who did not receive ECT (84% vs. 64%),
and ECT recipients lived an average of 17 miles closer to an
ECT facility than non-recipients (Table 1). Patients who
received ECT were more likely than non-recipients to live in
the Central region of US (28.0% vs. 19.7%) and less likely to
live in the West (20.2% vs. 24.3%). There was also a
statistically significant variation in rates of ECT use across
the VA VISNs (X2=105.7; df=20; pb0.0001), ranging from
1.5 to 36.0 ECT recipients per 10,000 depressed veterans.
3.3. Clinical and demographic predictors
In bivariate comparisons, patients who received ECT were
more likely to be 65 and older (33.6%) compared to depressed
patients who did not receive ECT (21.3%). Depressed veterans
who received ECT were more often white (88.6% vs. 72.0%)
and less often black (5.2% vs. 15.5%) than patients not treated
with ECT. Patients who received ECT were more likely to have
a comorbid personality disorder diagnosis (6.2% vs. 3.4%) but
there were no statistically significant differences in comor-
bidity with PTSD, other anxiety disorders, substance use
disorders, or having received a diagnosis of bipolar II disorder.
Patients who received ECT were less likely to have a major
medical comorbidity compared to those who did not receive
ECT (21.2% vs. 31.6%).
3.4. Multivariable analyses
Usinga regressionmodel that includedall predictor variables
simultaneously, depressed veterans were more likely to receive
ECT if they were aged 50–64 (OR: 1.63; 95% CI: 1.06–2.52) or
65+ (OR: 2.64; 95% CI: 1.67–4.18) when compared to younger
patients aged 18–39 (Table 1). When compared to white
patients, black patients were considerably less likely to receive
ECT (OR: 0.33; 95% CI: 0.20–0.55). Comorbid personality
disorders (OR: 2.20; 95% CI: 1.37–3.54) were associated with
an increased likelihood of receiving ECT, whereas other
comorbid psychiatric conditions were not associated with ECT.
Depressed veterans without a major medical comorbidity were
also more likely than those with a medical comorbidity to
receiveECT (OR:2.42; 95%CI: 1.65–3.55). Patientswhose closest
VA facility provided ECT were also more likely to receive ECT
(OR: 3.02; 95% CI: 2.22–4.10). Patients living in the Southern
(OR: 0.71; 95% CI: 0.53–0.95) and Western (OR: 0.59; 95% CI:
0.42–0.82) regions of the US were less likely to receive ECT
compared with those in the Central region.
4. Discussion
Within the VA health system, approximately 1 in 613
patients with major depression received ECT. It is difficult to
contextualize this finding with prior work in the VA and
general US population, which has relied on survey methods
and assessed populations other than those with major
depression (Hermann et al., 1995; Srinivasaraghavan and
Weiner, 1997). However, as treatment algorithms for chronic
depression recommend ECT after 3 or 4 failed psychotropic
medication trials, as many as 1 in 3 depressed patientsmay be
candidates for ECT after receiving sequenced antidepressant
treatment (Rush et al., 2006; Texas Department of State
Health Services, 2008; Trivedi and Kleiber, 2001). Given the
high rates of hospitalization, suicide, and comorbidity among
depressed VA patients, it is unlikely that this population has
less clinical need for ECT than more broadly representative
depressed populations (Blow et al., 2003; Valenstein et al.,
2009; Zivin et al., 2007). Our findings therefore suggest
under-utilization of ECT in this population.
Several patient-level characteristics not directly related to
clinical indication were associated with the receipt of ECT,
including local access to ECT services and patient race, age,
and general medical condition. Depressed veterans whose
closest VA facility offered ECT were approximately three
times more likely to receive ECT than those whose closest
facility did not offer ECT. Regional variation in ECT use was
evident in analyses of both larger US geographical regions and
the smaller VA administrative units or VISNs. Prior reports of
regional differences in ECT use, such as the historically low
use of ECT in California, have been attributed to the presence
Table 1
Characteristics of VA patients diagnosed with major depressive disorder and









63.6% 83.7% 3.02 (2.22, 4.10)
Age
18–40 years 13.2% 8.8% 1.00 Reference
40–49 years 21.9% 14.7% 1.08 (0.66, 1.74)
50–64 years 43.6% 43.0% 1.63 (1.06, 2.52)
65+ years 21.3% 33.6% 2.64 (1.67, 4.18)
Male sex 90.3% 91.2% 0.89 (0.59, 1.35)
Race
White 72.0% 88.6% 1.00 Reference
Black 15.5% 5.2% 0.33 (0.20, 0.55)
Other 2.6% 1.6% 0.61 (0.25, 1.48)
Unknown 9.9% 4.6% 0.42 (0.24, 0.73)
Hispanic ethnicity 5.9% 3.9% 0.61 (0.34, 1.09)
Posttraumatic stress
disorder
25.4% 25.4% 1.11 (0.84, 1.46)
Other anxiety disorder 19.3% 21.8% 1.08 (0.82, 1.42)
Personality disorder 3.4% 6.2% 2.20 (1.37, 3.54)
Bipolar II disorder 0.7% 0.7% 1.02 (0.25, 4.10)
Substance use disorder 20.6% 17.3% 0.97 (0.71, 1.33)
Service-connected
disability
35.7% 31.3% 0.85 (0.66, 1.10)
Charlson comorbidity
0 68.4% 78.8% 2.42 (1.65, 3.55)
1 15.2% 11.1% 1.22 (0.75, 1.99)
N1 16.5% 10.1% 1.00 Reference
US region
Central 19.7% 28.0% 1.00 Reference
Northeast 20.5% 18.6% 0.75 (0.54, 1.06)
South 35.5% 33.2% 0.71 (0.53, 0.95)
West 24.3% 20.2% 0.59 (0.42, 0.82)
a Adjusted odds ratio and 95% confidence intervals from a multivariable
logistic regression predicting receipt of ECT adjusted for all other variables
simultaneously.
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of managed care organizations and stricter state regulations
(Hermann et al., 1995; Kramer, 1997). As a federally funded
institution, treatment practices within the VA may be less
directly influenced by private health maintenance organiza-
tions (HMOs) or state regulations; however, these factors
may contribute to differences between VISNs and US regions
by affecting local practice patterns, training, or the availability
of psychiatrists capable of performing ECT.
African–Americans are just as likely as whites to benefit from
ECT, but African–Americansweremuch less likely to receive ECT,
consistent with a prior report from a single academic mental
health center (Breakey and Dunn, 2004; Williams et al., 2008).
African–Americans are also significantly less likely thanwhites to
receive guideline-concordant outpatient depression care even
thoughAfrican–Americans experience similar rates of depression
and are as likely as whites to initiate mental health treatment
(Cooper-Patrick et al., 1999; Rosenheck and Fontana, 1993;
Wang et al., 2000; Young et al., 2000). Future research should
explore whether provider bias or a lack of acceptance of ECT
treatment specifically among African–Americans contributes to
the disparities in ECT use.
Younger depressed veterans were less likely to receive ECT
than older veterans, consistent with prior reports of ECT use in
the US and with studies showing that patients with treatment
resistant depression are older than other depressed patients
(Crown et al., 2002; Kramer, 1997; Thompson and Blaine,
1987). Depressed veterans who received ECT were also more
likely to have a comorbid personality disorder, but ECT use was
not related to comorbid substance use disorders, anxiety
disorders (including PTSD), or bipolar II disorder. While it is
not surprising that patients with more complex psychopathol-
ogy are more likely to receive ECT, limited evidence suggests
that depressed patients with borderline personality disorder
(but not other personality disorders) may actually be less
responsive to ECT (Feske et al., 2004). Patients were also more
likely to receiveECT if theyhadnomajormedical comorbidities,
suggesting that treatment decisions regarding ECT may be
unduly influenced by the presence of medical comorbidities
given that ECT can usually be provided safely in these settings.
Our findings also have several implications for the VA and
other health systems. Improving access to ECT may result in
increased use as evidenced by the strong relationship
between the geographic proximity to an ECT-providing
facility and ECT receipt. However, disparities in ECT use
among patient subgroups and regional variation may not be
affected by simply improving access. Variation in health care
utilization occurs more frequently among discretionary
services than for guideline-based care; clearer practice
guidelines, perhaps including specific treatment algorithms,
may therefore be an important step towards reducing
disparities (Sirovich et al., 2008). Ensuring that health care
providers – psychiatrists in particular – are familiar with ECT
and its indications, particularly in minority patients or
individuals with medical comorbidities, may also improve
the effective and equitable use of ECT.
Our study is limited by the unavailability of several likely
important predictors of ECT use, such as measures of illness
severity, antidepressant treatment resistance, and patient or
provider attitudes. A strength of our study was the inclusion
of a sizeable and diverse patient population from the largest
coordinated health system in the US; we note, however, that
the relative importance of specific predictors may be different
in non-veteran populations. VA patients may have received
ECT in non-VA facilities; however, we included databases that
included information on non-VA ECT use and prior surveys
show low rates of referrals to outside facilities for ECT
(Srinivasaraghavan and Weiner, 1997). Finally, the VA has
made initiatives in recent years to enhancemental health care
and changes in ECT use resulting from these initiatives may
not be reflected in the current analyses.
5. Conclusions
Treatment with ECT is relatively uncommon within the VA
health system but is more likely among patients with local
access to the service; with fewer than half of the VA Medical
Centers providing ECT, the VA should consider further
increasing access to this highly effective treatment. Other
health systems should consider parallel efforts to monitor and
improve access to ECT. Racial disparities also exist and
subsequent research should address the contribution of patient
and provider attitudes towards the use of ECT. More specific
practice guidelines, implementation of treatment algorithms,
or other forms of provider decision support regarding use of
ECT should also be explored to ensure more consistent use.
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